Thiogenesis Therapeutics Corp (TSE:TTI)
TSXV:TTI
Canadian Market
Holding TSE:TTI?
Track your performance easily

Thiogenesis Therapeutics Corp (TTI) Financial Statements

1 Followers

Thiogenesis Therapeutics Corp Financial Overview

Thiogenesis Therapeutics Corp's market cap is currently ―. The company's EPS TTM is C$-0.107; its P/E ratio is -6.52; Thiogenesis Therapeutics Corp is scheduled to report earnings on November 18, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -710.57K$ -2.07M$ -1.05M$ -870.39K$ -1.07M
EBITDA$ -710.57K$ -2.07M$ -1.05M$ -870.39K$ -1.07M
Net Income Common Stockholders$ -710.57K$ -2.07M$ -1.05M$ -870.39K$ -1.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 5.52M$ 7.08M$ 3.63M$ 4.64M$ 5.32M
Total Assets$ 5.69M$ 7.24M$ 3.69M$ 4.70M$ 5.35M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -5.52M$ -7.08M$ -3.63M$ -4.64M$ -5.32M
Total Liabilities$ 344.60K$ 1.71M$ 320.44K$ 349.83K$ 258.00K
Stockholders Equity$ 5.34M$ 5.53M$ 3.37M$ 4.35M$ 5.09M
Cash Flow-
Free Cash Flow$ -2.00M$ -696.61K$ -991.64K$ -685.15K$ -875.06K
Operating Cash Flow$ -2.00M$ -696.61K$ -991.64K$ -685.15K$ -875.06K
Investing Cash Flow-----
Financing Cash Flow$ 462.50K$ 4.12M---
Currency in USD

Thiogenesis Therapeutics Corp Earnings and Revenue History

Thiogenesis Therapeutics Corp Debt to Assets

Thiogenesis Therapeutics Corp Cash Flow

Thiogenesis Therapeutics Corp Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis